Home › Compare › TMXN vs MRK

TMXN vs MRK: Dividend Comparison 2026

TMXN yields 100000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TMXN wins by $4.832206901976048e+26M in total portfolio value
10 years
TMXN
TMXN
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full TMXN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TMXN vs MRK

📍 TMXN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTMXNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TMXN + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TMXN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMXN
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TMXN beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMXN + MRK for your $10,000?

TMXN: 50%MRK: 50%
100% MRK50/50100% TMXN
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TMXN
No analyst data
Altman Z
-5783.1
Piotroski
0/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMXN buys
0
MRK buys
0
No recent congressional trades found for TMXN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTMXNMRK
Forward yield100000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$4.832206901976048e+26M$56.8K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$4.8315851896727036e+26M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TMXN vs MRK ($10,000, DRIP)

YearTMXN PortfolioTMXN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,010,700$10,000,000.00$11,206$366.19+$10.00M → TMXN
2$9,366,505,842$9,355,794,392.52$12,650$502.35+$9366.49M → TMXN
3$8,191,091,111,834$8,181,068,950,583.78$14,407$694.19+$8191091.10M → TMXN
4$6,695,134,751,499,451$6,686,370,284,009,789.00$16,585$967.82+$6695134751.48M → TMXN
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$19,342$1,363.89+$5114850040116.01M → TMXN
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$22,913$1,947.19+$3652290278277141.00M → TMXN
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$27,662$2,823.89+$2437583176648375296.00M → TMXN
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$34,159$4,173.35+$1.5206125080790106e+21M → TMXN
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$43,337$6,308.80+$8.866373796011065e+23M → TMXN
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$56,776$9,798.13+$4.832206901976048e+26M → TMXN

TMXN vs MRK: Complete Analysis 2026

TMXN — Stock

Trimax Corporation provides mobile apps and Web development solutions. It offers application development, Web application development, technology consulting, cloud services, and e-commerce or business intelligence and analytics. The company is also involved in production of olives and organic farming; provision of coffee; real estate development; and tourism activities. In addition, it engages in the design, manufacture, sale, export, and after-sales service of yachts and yacht parts. The company is based in Ft Lauderdale, Florida.

Full TMXN Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TMXN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMXN vs SCHDTMXN vs JEPITMXN vs OTMXN vs KOTMXN vs MAINTMXN vs JNJTMXN vs ABBVTMXN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.